Nicolas Guisot

Nicolas Guisot

Company: RedX Pharma

Job title: Research Fellow


Pipeline Peak 4: GI Restricted ROCK Inhibitor RXC008 for The Treatment of Fibrotic Strictures in Crohn’s Disease 9:40 am

Strictures have no current pharmaceutical treatment RXC008 is a potent anti-fibrotic that has the promise to be one of the first effective therapies to reverse stricture formation RXC008 may also protect GI tissues from inflammatory injury and enhance mucosal healingRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.